Hugh A. Barton

4.6k total citations
102 papers, 3.5k citations indexed

About

Hugh A. Barton is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Pharmacology. According to data from OpenAlex, Hugh A. Barton has authored 102 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Health, Toxicology and Mutagenesis, 34 papers in Cancer Research and 30 papers in Pharmacology. Recurrent topics in Hugh A. Barton's work include Carcinogens and Genotoxicity Assessment (34 papers), Effects and risks of endocrine disrupting chemicals (30 papers) and Pharmacogenetics and Drug Metabolism (29 papers). Hugh A. Barton is often cited by papers focused on Carcinogens and Genotoxicity Assessment (34 papers), Effects and risks of endocrine disrupting chemicals (30 papers) and Pharmacogenetics and Drug Metabolism (29 papers). Hugh A. Barton collaborates with scholars based in United States, United Kingdom and Canada. Hugh A. Barton's co-authors include Melvin E. Andersen, Harvey J. Clewell, Rui Li, John C. Lipscomb, R. Woodrow Setzer, Kannan Krishnan, Justin Teeguarden, Hannah M. Jones, Yurong Lai and Tristan S. Maurer and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Environmental Health Perspectives.

In The Last Decade

Hugh A. Barton

101 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hugh A. Barton United States	34	1.3k	888	784	761	515	102	3.5k
John C. Lipscomb United States	26	1.1k 0.9×	662 0.7×	611 0.8×	309 0.4×	355 0.7×	69	2.6k
Sami Haddad Canada	35	1.2k 0.9×	536 0.6×	451 0.6×	430 0.6×	327 0.6×	117	3.0k
Stephen Ferguson United States	38	1.1k 0.9×	1.6k 1.8×	572 0.7×	795 1.0×	1.6k 3.2×	108	5.1k
Roger Rahmani France	43	1.3k 1.0×	1.2k 1.3×	514 0.7×	1.1k 1.5×	1.3k 2.6×	137	4.9k
John R. Foster United Kingdom	39	1.2k 0.9×	811 0.9×	873 1.1×	746 1.0×	1.5k 3.0×	125	4.4k
Douglas C. Wolf United States	42	1.6k 1.3×	516 0.6×	1.1k 1.4×	377 0.5×	1.4k 2.8×	209	5.8k
Bas J. Blaauboer Netherlands	37	1.4k 1.1×	885 1.0×	661 0.8×	397 0.5×	1.3k 2.6×	134	4.6k
Clifford R. Elcombe United Kingdom	40	1.5k 1.2×	2.1k 2.4×	970 1.2×	1.1k 1.5×	2.4k 4.6×	93	5.7k
Lois D. Lehman‐McKeeman United States	32	698 0.5×	503 0.6×	532 0.7×	415 0.5×	954 1.9×	93	2.9k
Ronald N. Hines United States	45	1.1k 0.8×	2.5k 2.9×	866 1.1×	1.2k 1.6×	1.6k 3.1×	128	6.4k

Countries citing papers authored by Hugh A. Barton

Since Specialization

Citations

This map shows the geographic impact of Hugh A. Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugh A. Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugh A. Barton more than expected).

Fields of papers citing papers by Hugh A. Barton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hugh A. Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugh A. Barton. The network helps show where Hugh A. Barton may publish in the future.

Co-authorship network of co-authors of Hugh A. Barton

This figure shows the co-authorship network connecting the top 25 collaborators of Hugh A. Barton. A scholar is included among the top collaborators of Hugh A. Barton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugh A. Barton. Hugh A. Barton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Craig, Ashley, et al.. (2024). Nicotine is an Immunosuppressant: Implications for Women's Health and Disease. Journal of Neuroimmunology. 397. 578468–578468. 2 indexed citations

Hoer, Daniel, Hugh A. Barton, Alicia Paini, et al.. (2022). Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling. Toxicology and Applied Pharmacology. 440. 115922–115922. 6 indexed citations

Li, Rui & Hugh A. Barton. (2017). Explaining Ethnic Variability of Transporter Substrate Pharmacokinetics in Healthy Asian and Caucasian Subjects with Allele Frequencies of OATP1B1 and BCRP: A Mechanistic Modeling Analysis. Clinical Pharmacokinetics. 57(4). 491–503. 25 indexed citations

Li, Rui, Avijit Ghosh, Tristan S. Maurer, Emi Kimoto, & Hugh A. Barton. (2014). Physiologically Based Pharmacokinetic Prediction of Telmisartan in Human. Drug Metabolism and Disposition. 42(10). 1646–1655. 33 indexed citations

Li, Rui, Hugh A. Barton, Phillip D. Yates, et al.. (2014). A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling. Journal of Pharmacokinetics and Pharmacodynamics. 41(3). 197–209. 62 indexed citations

Johnson, Martin, Magdalena Kozielska, Venkatesh Pilla Reddy, et al.. (2014). Dopamine D2 Receptor Occupancy as a Predictor of Catalepsy in Rats: A Pharmacokinetic-Pharmacodynamic Modeling Approach. Pharmaceutical Research. 31(10). 2605–2617. 12 indexed citations

Thompson, Chad M., Douglas O. Johns, Babasaheb Sonawane, et al.. (2008). Database for Physiologically Based Pharmacokinetic (PBPK) Modeling: Physiological Data for Healthy and Health-Impaired Elderly. Journal of Toxicology and Environmental Health Part B. 12(1). 1–24. 72 indexed citations

Wambaugh, John F., Christopher Lau, Andrew B. Lindstrom, et al.. (2008). Modeling Single and Repeated Dose Pharmacokinetics of PFOA in Mice. Toxicological Sciences. 107(2). 331–341. 93 indexed citations

Lu, Yasong, Susan Rieth, Manupat Lohitnavy, et al.. (2008). Application of PBPK modeling in support of the derivation of toxicity reference values for 1,1,1-trichloroethane. Regulatory Toxicology and Pharmacology. 50(2). 249–260. 18 indexed citations

10.

Wambaugh, John F., Hugh A. Barton, & R. Woodrow Setzer. (2008). Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis. Journal of Pharmacokinetics and Pharmacodynamics. 35(6). 683–712. 12 indexed citations

11.

Yoon, Miyoung & Hugh A. Barton. (2007). Predicting Maternal Rat and Pup Exposures: How Different are They?. Toxicological Sciences. 102(1). 15–32. 16 indexed citations

12.

Mahle, Deirdre A., Jeffery M. Gearhart, Claude C. Grigsby, et al.. (2007). Age-Dependent Partition Coefficients for a Mixture of Volatile Organic Solvents in Sprague-Dawley Rats and Humans. Journal of Toxicology and Environmental Health. 70(20). 1745–1751. 18 indexed citations

13.

Barton, Hugh A., Timothy P. Pastoor, Karl P. Baetcke, et al.. (2006). The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments. Critical Reviews in Toxicology. 36(1). 9–35. 101 indexed citations

14.

Barton, Hugh A., et al.. (2005). Assessing Susceptibility from Early-Life Exposure to Carcinogens. Environmental Health Perspectives. 113(9). 1125–1133. 103 indexed citations

15.

Teeguarden, Justin, Torka S. Poet, J. Caroline English, et al.. (2005). Derivation of a Human Equivalent Concentration for n-Butanol Using A Physiologically Based Pharmacokinetic Model for n-Butyl Acetate and Metabolites n-Butanol and n-Butyric Acid. Toxicological Sciences. 85(1). 429–446. 29 indexed citations

16.

Setzer, R. Woodrow, et al.. (2004). Framework for Evaluation of Physiologically‐Based Pharmacokinetic Models for Use in Safety or Risk Assessment. Risk Analysis. 24(6). 1697–1717. 60 indexed citations

17.

Barton, Hugh A. & Harvey J. Clewell. (2000). Evaluating noncancer effects of trichloroethylene: dosimetry, mode of action, and risk assessment.. Environmental Health Perspectives. 108(suppl 2). 323–334. 41 indexed citations

18.

Andersen, Melvin E. & Hugh A. Barton. (1998). The use of biochemical and molecular parameters to estimate dose-response relationships at low levels of exposure.. Environmental Health Perspectives. 106(suppl 1). 349–355. 19 indexed citations

19.

Andersen, Melvin E., Harvey J. Clewell, Jeffrey Gearhart, Bruce C. Allen, & Hugh A. Barton. (1997). PHARMACODYNAMIC MODEL OF THE RAT ESTRUS CYCLE IN RELATION TO ENDOCRINE DISRUPTORS. Journal of Toxicology and Environmental Health. 52(3). 189–209. 18 indexed citations

20.

Barton, Hugh A., Carlyle D. Flemming, & John C. Lipscomb. (1996). Evaluating human variability in chemical risk assessment: hazard identification and dose-response assessment for noncancer oral toxicity of trichloroethylene. Toxicology. 111(1-3). 271–287. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact